| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |